3p21.3 tumor suppressor gene RBM5 inhibits growth of human prostate cancer PC-3 cells through apoptosis

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Zhao, Lijing ^b,c   Li, Ranwei ^a   Shao, Chen ^b,c   Li, Ping ^a   Liu, Jian ^b   Wang, Ke ^a  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b Basic Medical College   (China)

^c CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Apoptosis; Gene expression; PC 3; Prostate cancer; RBM5

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; MEMBRANE PROTEIN; RNA BINDING PROTEIN; RNA BINDING PROTEIN RBM5; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN 3P21.3; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL VIABILITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC NEOPLASMS; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 84869045956     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-247     Document Type: Article

References (33)

1. Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, Bray F. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012, 61:1079-1092. 10.1016/j.eururo.2012.02.054, 22424666.
2. Zhang L, Wu S, Guo LR, Zhao XJ. Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China. Asian J Androl 2009, 11:9-13. 10.1038/aja.2008.21, 19050685.
3. Klein EA, Kupelian PA. Localized prostate cancer: radiation or surgery?. Urol Clin North Am 2003, 30:315-330. ix, 10.1016/S0094-0143(02)00179-9, 12735507.
4. Kok K, Naylor SL, Buys CH. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 1997, 71:27-92.
5. Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon JW, Garner HR, McKay B, Latif F, Lerman MI, Lam S, Gazdar AF, Minna JD. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 2000, 60:1949-1960.
6. Ji L, Minna JD, Roth JA. 3p21.3 tumor suppressor cluster: prospects for translational applications. Future Oncol 2005, 1:79-92. 10.1517/14796694.1.1.79, 16555978.
7. Mourtada-Maarabouni M, Sutherland LC, Meredith JM, Williams GT. Simultaneous acceleration of the cell cycle and suppression of apoptosis by splice variant delta-6 of the candidate tumour suppressor LUCA-15/RBM5. Genes Cells 2003, 8:109-119. 10.1046/j.1365-2443.2003.00619.x, 12581154.
8. Edamatsu H, Kaziro Y, Itoh H. LUCA15, a putative tumour suppressor gene encoding an RNA-binding nuclear protein, is down-regulated in ras-transformed Rat-1 cells. Genes Cells 2000, 5:849-858. 10.1046/j.1365-2443.2000.00370.x, 11029660.
9. Welling DB, Lasak JM, Akhmametyeva E, Ghaheri B, Chang LS. cDNA microarray analysis of vestibular schwannomas. Otol Neurotol 2002, 23:736-748. 10.1097/00129492-200209000-00022, 12218628.
10. Oh JJ, West AR, Fishbein MC, Slamon DJ. A candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3. Cancer Res 2002, 62:3207-3213.
11. Liang H, Zhang J, Shao C, Zhao L, Xu W, Sutherland LC, Wang K. Differential expression of RBM5. EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues. J Exp Clin Cancer Res 2012, 31:36. 10.1186/1756-9966-31-36, 3403968, 22537942.
12. Sutherland LC, Wang K, Robinson AG. RBM5 as a putative tumor suppressor gene for lung cancer. J Thorac Oncol 2010, 5:294-298. 10.1097/JTO.0b013e3181c6e330, 20186023.
13. Maarabouni MM, Williams GT. The antiapoptotic RBM5/LUCA-15/H37 gene and its role in apoptosis and human cancer: research update. ScientificWorldJournal 2006, 6:1705-1712. 1825760, 17195868.
14. Oh JJ, Razfar A, Delgado I, Reed RA, Malkina A, Boctor B, Slamon DJ. 3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis. Cancer Res 2006, 66:3419-3427. 10.1158/0008-5472.CAN-05-1667, 16585163.
15. Li P, Wang K, Zhang J, Zhao L, Liang H, Shao C, Sutherland LC. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin. Cancer Epidemiol 2012, 36:481-489. 10.1016/j.canep.2012.04.004, 22609235.
16. Rintala-Maki ND, Abrasonis V, Burd M, Sutherland LC. Genetic instability of RBM5/LUCA-15/H37 in MCF-7 breast carcinoma sublines may affect susceptibility to apoptosis. Cell Biochem Funct 2004, 22:307-313. 10.1002/cbf.1106, 15338470.
17. Senchenko VN, Liu J, Loginov W, Bazov I, Angeloni D, Seryogin Y, Ermilova V, Kazubskaya T, Garkavtseva R, Zabarovska VI, Kashuba VI, Kisselev LL, Minna JD, Lerman MI, Klein G, Braga EA, Zabarovsky ER. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene 2004, 23:5719-5728. 10.1038/sj.onc.1207760, 15208675.
18. Rintala-Maki ND, Sutherland LC. LUCA-15/RBM5, a putative tumour suppressor, enhances multiple receptor-initiated death signals. Apoptosis 2004, 9:475-484.
19. Sutherland LC, Edwards SE, Cable HC, Poirier GG, Miller BA, Cooper CS, Williams GT. LUCA-15-encoded sequence variants regulate CD95-mediated apoptosis. Oncogene 2000, 19:3774-3781. 10.1038/sj.onc.1203720, 10949932.
20. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002, 108:153-164. 10.1016/S0092-8674(02)00625-6, 11832206.
21. Hsu JL, Ho YF, Li TK, Chen CS, Hsu LC, Guh JH. Rottlerin potentiates camptothecin-induced cytotoxicity in human hormone refractory prostate cancers through increased formation and stabilization of topoisomerase I-DNA cleavage complexes in a PKCdelta-independent pathway. Biochem Pharmacol 2012, 84:59-67. 10.1016/j.bcp.2012.03.023, 22490701.
22. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003, 33:49-54. 10.1038/ng1060, 12469122.
23. Kotlajich MV, Hertel KJ. Death by splicing: tumor suppressor RBM5 freezes splice-site pairing. Mol Cell 2008, 32:162-164. 10.1016/j.molcel.2008.10.008, 18951082.
24. Farina B, Fattorusso R, Pellecchia M. Targeting zinc finger domains with small molecules: solution structure and binding studies of the RanBP2-type zinc finger of RBM5. Chembiochem 2011, 12:2837-2845. 10.1002/cbic.201100582, 3408030, 22162216.
25. Sutherland LC, Lerman M, Williams GT, Miller BA. LUCA-15 suppresses CD95-mediated apoptosis in Jurkat T cells. Oncogene 2001, 20:2713-2719. 10.1038/sj.onc.1204371, 11420683.
26. Oh JJ, Taschereau EO, Koegel AK, Ginther CL, Rotow JK, Isfahani KZ, Slamon DJ. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis. Lung Cancer 2010, 70:253-262. 10.1016/j.lungcan.2010.02.012, 20338664.
27. Kobayashi T, Ishida J, Musashi M, Ota S, Yoshida T, Shimizu Y, Chuma M, Kawakami H, Asaka M, Tanaka J, Imamura M, Kobayashi M, Itoh H, Edamatsu H, Sutherland LC, Brachmann RK. p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5. Int J Cancer 2011, 128:304-318. 10.1002/ijc.25345, 20309933.
28. Walensky LD, Gavathiotis E. BAX unleashed: the biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial pore. Trends Biochem Sci 2011, 36:642-652. 10.1016/j.tibs.2011.08.009, 3454508, 21978892.
29. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002, 2:647-656. 10.1038/nrc883, 12209154.
30. Kaufmann T, Strasser A, Jost PJ. Fas death receptor signalling: roles of Bid and XIAP. Cell Death Differ 2012, 19:42-50. 10.1038/cdd.2011.121, 3252833, 21959933.
31. Li JY, Furuichi Y, Matsuoka N, Mutoh S, Yanagihara T. Tacrolimus (FK506) attenuates biphasic cytochrome c release and Bad phosphorylation following transient cerebral ischemia in mice. Neuroscience 2006, 142:789-797. 10.1016/j.neuroscience.2006.06.064, 16935431.
32. Premkumar DR, Jane EP, DiDomenico JD, Vukmer NA, Agostino NR, Pollack IF. ABT-737 synergizes with bortezomib to induce apoptosis, mediated by Bid cleavage, Bax activation, and mitochondrial dysfunction in an Akt-dependent context in malignant human glioma cell lines. J Pharmacol Exp Ther 2012, 341:859-872. 10.1124/jpet.112.191536, 22393246.
33. Garrison SP, Phillips DC, Jeffers JR, Chipuk JE, Parsons MJ, Rehg JE, Opferman JT, Green DR, Zambetti GP. Genetically defining the mechanism of Puma- and Bim-induced apoptosis. Cell Death Differ 2012, 19:642-649. 10.1038/cdd.2011.136, 22015606.